Veterinary OA market growth is accelerating rapidly as companion animal healthcare becomes a major priority for pet owners and veterinary professionals worldwide. Osteoarthritis is one of the most common chronic diseases affecting aging pets, leading to pain, mobility limitations, and reduced quality of life. Increasing awareness regarding early diagnosis and advanced treatment options is significantly driving the expansion of the companion animal osteoarthritis market.
According to Polaris Market Research, the global companion animal osteoarthritis market was valued at USD 2.26 billion in 2024 and is forecast to reach USD 18.45 billion by 2034, growing at a CAGR of 23.4% during the forecast period. The market is benefiting from increased pet healthcare spending, rising companion animal ownership, and growing adoption of innovative veterinary therapies.
One of the primary drivers behind veterinary OA market growth is the rising prevalence of osteoarthritis in aging pets. Older animals are more likely to develop chronic joint degeneration and mobility issues, creating sustained demand for long-term treatment solutions. Improved veterinary care and nutrition are helping pets live longer, which is increasing the incidence of age-related orthopedic conditions.
The growing adoption of biologics is playing a major role in transforming the companion animal osteoarthritis market. Biologics accounted for approximately 54% of market revenue in 2024 because they target the underlying causes of osteoarthritis rather than simply masking symptoms. Stem cell therapies, platelet-rich plasma injections, and monoclonal antibody treatments are becoming increasingly common in veterinary medicine.
Canine animals represented the largest market share in 2024 due to the high occurrence of osteoarthritis among large-breed and aging dogs. Veterinarians are increasingly recommending advanced pain management solutions and rehabilitation programs to maintain canine mobility and reduce chronic discomfort.
Injectable therapies continue to dominate the market due to their rapid onset of action and ability to provide extended pain relief. Injectable biologics are especially valuable for severe osteoarthritis cases where immediate symptom management is required. These therapies are gaining popularity because they offer minimally invasive treatment options with improved clinical outcomes.
Veterinary medicine is also witnessing increased adoption of specialized orthopedic procedures. Clinics are expanding services related to arthroscopy, joint replacement, corrective surgeries, and regenerative medicine. These advanced procedures improve treatment effectiveness and create additional revenue opportunities for veterinary healthcare providers.
Read More @ https://www.polarismarketresearch.com/industry-analysis/companion-animal-osteoarthritis-market
The veterinary hospitals and clinics segment accounted for the largest revenue share in 2024 because these facilities serve as the primary centers for diagnosis and treatment. Pet owners rely heavily on veterinarian recommendations for osteoarthritis care plans, including prescription therapies, rehabilitation services, and biologic injections.
Technological advancements in imaging and diagnostics are also fueling veterinary OA market growth. Improved imaging tools allow earlier identification of joint degeneration, enabling veterinarians to implement treatment plans before conditions become severe. Early intervention improves long-term mobility outcomes and increases demand for ongoing therapies and rehabilitation programs.
North America maintained the largest share of the companion animal osteoarthritis market in 2024 due to strong veterinary infrastructure, advanced treatment availability, and high consumer spending on pet healthcare. Europe continues to experience steady growth because of rising awareness regarding companion animal wellness and geriatric care.
Asia Pacific is expected to emerge as one of the fastest-growing regions between 2025 and 2034. Rising urbanization, expanding veterinary services, and increasing pet adoption rates are encouraging greater investment in osteoarthritis treatments across countries such as China, India, and Japan.
The expansion of digital veterinary platforms and e-commerce channels is further improving market accessibility. Online consultations, prescription delivery services, and subscription-based medication programs are making osteoarthritis treatment solutions more convenient for pet owners worldwide.
As the demand for advanced veterinary healthcare continues to rise, veterinary OA market growth is expected to remain strong over the next decade. Continued innovation in biologics, orthopedic therapies, diagnostics, and rehabilitation technologies will play a critical role in shaping the future of the companion animal osteoarthritis market.
More Trending Latest Reports By Polaris Market Research:
Oil Condition Monitoring Market
Polycystic Ovary Syndrome Supplements Market
Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek